Validating the use of a luciferase labeled breast cancer cell line, MDA435LCC6, as a means to monitor tumor progression and to assess the therapeutic activity of an established anticancer drug, docetaxel (Dt) alone or in combination with the ILK inhibitor, QLT0267.

Details

Language :

English

ISSN :

15384047

Volume :

11

Issue :

9

Database :

Complementary Index

Journal :

Cancer Biology & Therapy

Publication Type :

Academic Journal

Accession number :

65362194

Full Text :

https://doi.org/10.4161/cbt.11.9.15183